Skip to content

[Diagnostic performance analysis of targeted biopsy versus combined targeted and systematic biopsy in patients with PI-RADS 4-5 lesions].

Aug 2026 · Zhonghua zhong liu za zhi [Chinese journal of oncology] · Vol 48 8, pp. 991-997 · 0 citations
Medicine

TL;DR

For patients with PI-RADS 4-5 lesions, TB may serve as a clinically equivalent alternative to combined biopsy, achieving comparable diagnostic efficacy while reducing procedural burden on both patients and healthcare systems.

View source

Similar papers

Open access Sep 2026

Targeted biopsy plus systematic biopsy versus targeted saturation biopsy plus systematic biopsy for the detection of clinically significant prostate cancer: A comparative study

ABSTRACT Introduction: Multiparametric magnetic resonance imaging (mpMRI)-guided targeted biopsy (TB) has improved the detection of clinically significant prostate cancer (csPCa). This study compared the diagnostic performance of TB versus targeted saturation biopsy (TS), both in addition to standard 12-core systematic...

Ashish Varshney, U. Sharma, H. Goel et al. · 0 citations
Open access Oct 2026

Ipsilateral versus full systematic sampling combined with cognitive MRI-targeted biopsy for prostate cancer detection in biopsy-naïve men with unilateral mpMRI lesions: a retrospective paired cohort study

To evaluate whether restricting systematic biopsy to the ipsilateral side of a unilateral multiparametric magnetic resonance imaging (mpMRI) lesion, in combination with cognitive MRI-targeted biopsy, affects the detection of clinically significant prostate cancer (csPCa) in biopsy-naïve patients. This retr...

G. Tsakaldimis, D. Diamantidis, Nikolaos Smyrlis et al. · 0 citations
Sep 2026

[Transition to personalized software mpMR/US fusion prostate biopsy: a stratified retrospective analysis of 322 patients with development of a CHAID model].

INTRODUCTION MRI-targeted biopsy is the standard method for prostate cancer diagnosis; however, it is typically supplemented with perilesional or systematic biopsy to minimize the risk of false-negative results. Nevertheless, several studies have demonstrated the feasibility of performing MRI-targeted biopsy alone in c...

S. V, A. I, K. V et al. · 0 citations
Review Open access Sep 2026

Evaluating the biopsy-negative prostate lesions based on sequential biparametric prostate magnetic resonance imaging: Can PRECISE be used to guide repeat biopsy?

The effectiveness of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) scoring system as a guide for repeat biopsy is investigated, suggesting its potential to help reduce unnecessary repeat biopsies for regressing lesions while identifying high-risk progressing abnormalities.

Yuxuan Tian, Ming-Jian Ruan, Yu-Ke Chen et al. · 0 citations
Open access Aug 2026

Association of PI-RADS Score with Clinically Significant Prostate Cancer and Histopathological Upgrading in Patients Undergoing Radical Prostatectomy: A Retrospective Single-Centre Study

Background and Objectives: Multiparametric magnetic resonance imaging (mpMRI) is widely used in prostate cancer diagnosis, but biopsy findings may still underestimate tumor aggressiveness. This study evaluated the association of Prostate Imaging Reporting and Data System (PI-RADS) assessment with clinically significant...

H. A. Krzepkowski, T. Ząbkowski, A. Wieczorek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.